Elevated serum levels of interleukin-17A in uveitis patients

Ocular Immunology and Inflammation

Volumn 21, Issue 6, 2013, Pages 434-439

  Jawad, Shayma ^a   Liu, Baoying ^a   Agron, Elvira ^a   Nussenblatt, Robert B ^a   Sen, H Nida ^a  

^a NATIONAL EYE INSTITUTE   (United States)

Author keywords

Cytokine; Interleukin 17; Serum, Th17; Uveitis

Indexed keywords

AZATHIOPRINE; CORTICOSTEROID; CYCLOSPORIN; INFLIXIMAB; INTERLEUKIN 17; METHOTREXATE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER;

ADULT; AGED; ARTICLE; AUTOIMMUNE UVEITIS; CASE CONTROL STUDY; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE ACTIVITY; DISEASE ASSOCIATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; PROTEIN BLOOD LEVEL; SYSTEMIC THERAPY;

ADOLESCENT; ADULT; AGED; AUTOIMMUNE DISEASES; CHILD; DISEASE PROGRESSION; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNITY, CELLULAR; INTERLEUKIN-17; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; TH17 CELLS; UVEITIS; YOUNG ADULT;

EID: 84887956597     PISSN: 09273948     EISSN: 17445078     Source Type: Journal    
DOI: 10.3109/09273948.2013.815786     Document Type: Article

References (33)

1. Marwaha AK, Leung NJ, McMurchy AN, Levings MK. TH17 cells in autoimmunity and immunodeficiency: Protective or pathogenic? Frontiers Immunol. 2012; 3: 129
2. Bending D, Newland S, Krejci A, et al. Epigenetic changes at Il12rb2 and Tbx21 in relation to plasticity behavior of Th17 cells. J Immunol. 2011; 186: 3373-3382
3. Gaffen SL. An overview of IL-17 function and signaling. Cytokine. 2008; 43: 402-407
4. Caspi R. Autoimmunity in the immune privileged eye: Pathogenic and regulatory T cells. Immunol Res. 2008; 42: 41-50
5. Luger D, Caspi RR. New perspectives on effector mechanisms in uveitis. Semin Immunopathol. 2008; 30: 135-143
6. Li J, Chen X, Liu Z, et al. Expression of Th17 cytokines in skin lesions of patients with psoriasis. J Huazhong U Sci-Med. 2007; 27: 330-332
7. Cascao R, Moura RA, Perpetuo I, et al. Identification of a cytokine network sustaining neutrophil and Th17 activation in untreated early rheumatoid arthritis. Arthritis Res Therapy. 2010; 12: R196
8. Wong CK, Lit LC, Tam LS, et al. Hyperproduction of IL-23 and IL-17 in patients with systemic lupus erythematosus: Implications for Th17-mediated inflammation in auto-immunity. Clin Immunol. 2008; 127: 385-393
9. Mei Y, Pan F, Gao J, et al. Increased serum IL-17 and IL-23 in the patient with ankylosing spondylitis. Clin Rheumatol. 2011; 30: 269-273
10. Fujino S, Andoh A, Bamba S, et al. Increased expression of interleukin 17 in inflammatory bowel disease. Gut. 2003; 52: 65-70
11. Amadi-Obi A, Yu CR, Liu X, et al. TH17 cells contribute to uveitis and scleritis and are expanded by IL-2 and inhibited by IL-27/STAT1. Nature Med. 2007; 13: 711-718
12. Chen Y, Yang P, Li F, Kijlstra A. The effects of Th17 cytokines on the inflammatory mediator production and barrier function of ARPE-19 cells. PloS One. 2011; 6: E18139
13. Hamzaoui K, Bouali E, Ghorbel I, et al. Expression of Th-17 and RORgammat mRNA in behçet' s disease. Med Sci Monitor. 2011; 17: CR227-CR234
14. Chi W, Zhu X, Yang P, et al. Upregulated IL-23 and IL-17 in behçet patients with active uveitis. Invest Ophthalmol Visual Sci. 2008; 49: 3058-3064
15. Chi W, Yang P, Li B, et al. IL-23 promotes CD4þ T cells to produce IL-17 in Vogt-Koyanagi-Harada disease. J Allergy Clin Immunol. 2007; 119: 1218-1224
16. Kuiper JJ, Mutis T, de Jager W, et al. Intraocular interleukin-17 and proinflammatory cytokines in HLAA29- associated birdshot chorioretinopathy. Am J Ophthalmol. 2011; 152: 177-182 e171
17. Jabs DA, Nussenblatt RB, Rosenbaum JT. Standardization of uveitis nomenclature for reporting clinical data: Results of the First International Workshop. Am J Ophthalmol. 2005; 140: 509-516
18. Herbort CP, Rao NA, Mochizuki M, members of Scientific Committee of First International Workshop on Ocular S. International criteria for the diagnosis of ocular sarcoidosis: Results of the first International Workshop On Ocular Sarcoidosis (IWOS). Ocul Immunol Inflamm. 2009; 17: 160-169
19. Thompson IA, Liu B, Sen HN, et al. Association of complement factor h tyrosine 402 histidine genotype with posterior involvement in sarcoid-related uveitis. Am J Ophthalmol. 2013; 155: 1068-1074 e1061
20. International Study Group for behçet' s Disease. Criteria for diagnosis of behçet' s disease. Lancet. 1990; 335: 1078-1080
21. The International Study Group for behçet' s Disease. Evaluation of diagnostic (' classification') criteria in behçet' s disease - towards internationally agreed criteria. Br J Rheumatol. 1992; 31: 299-308
22. Behçet' s Disease Research Committee. Clinical research section recommendations. Jpn J Ophthalmol. 1974; 18: 291-294
23. Furusato E, Shen D, Cao X, et al. Inflammatory cytokine and chemokine expression in sympathetic ophthalmia: A pilot study. Histol Histopathol. 2011; 26: 1145-1151
24. Wendling D, Toussirot E. Bone and matrix remodeling markers: A new tool for assessment of treatment efficacy in ankylosing spondylitis? J Rheumatol. 2007; 34: 1647-1649
25. Chen WS, Chang YS, Lin KC, et al. Association of serum interleukin-17 and interleukin-23 levels with disease activity in Chinese patients with ankylosing spondylitis. J Chin Med Assoc. 2012; 75: 303-308
26. Metawi SA, Abbas D, Kamal MM, Ibrahim MK. Serum and synovial fluid levels of interleukin-17 in correlation with disease activity in patients with RA. Clin Rheumatol. 2011; 30: 1201-1207
27. Hamzaoui K, Hamzaoui A, Guemira F, et al. Cytokine profile in behçet' s disease patients: Relationship with disease activity. Scand J Rheumatol. 2002; 31: 205-210
28. Londono J, Romero-Sanchez MC, Torres VG, et al. The association between serum levels of potential biomarkers with the presence of factors related to the clinical activity and poor prognosis in spondyloarthritis. Rev Bras Reumatol. 2012; 52: 536-544
29. Sugita S, Horie S, Yamada Y, et al. Suppression of interleukin-17- roducing T-helper 17 cells by retinal pigment epithelial cells. Jpn J Ophthalmol. 2011; 55: 565-575
30. Chi W, Yang P, Zhu X, et al. Production of interleukin-17 in behçet' s disease is inhibited by cyclosporin A. Mol Vision. 2010; 16: 880-886
31. Hueber W, Patel DD, Dryja T, et al. Effects of AIN457, a fully human antibody to interleukin-17A, on psoriasis, rheumatoid arthritis, and uveitis. Sci Transl Med. 2010; 2: 52ra72
32. Dick AD, Tugal-Tutkun I, Foster S, et al. Secukinumab in the treatment of noninfectious uveitis: Results of three randomized, controlled clinical trials. Ophthalmology. 2013; 120: 777-787
33. Kang MH, Kim MK, Lee HJ, et al. Interleukin-17 in various ocular surface inflammatory diseases. J Korean Med Sci. 2011; 26: 938-944